Novocure Ltd (NVCR)

[jondoeuk]

AACR:

387 / 23 - Blood brain barrier (BBB) disruption by tumor treating fields (TTFields) in a human 3D in vitro model https://www.abstractsonline.com/pp8/#!/10517/presentation/12182

1305 / 15 - Tumor Treating Fields (TTFields) promote a pro-inflammatory phenotype in macrophages https://www.abstractsonline.com/pp8/#!/10517/presentation/16885

1801 / 30 - Application of Tumor Treating Fields (TTFields) to cancer cells enhances their membrane permeability https://www.abstractsonline.com/pp8/#!/10517/presentation/20545

1866 / 11 - Transcriptomics analysis for identification of pathways involved in the response to Tumor Treating Fields (TTFields) https://www.abstractsonline.com/pp8/#!/10517/presentation/16328

2037 / 15 - Spatial omic changes of malignant pleural mesothelioma following treatment using tumor-treating fields https://www.abstractsonline.com/pp8/#!/10517/presentation/12731

2601 / 14 - Concomitant treatment of ovarian cell lines with Tumor Treating Fields (TTFields) and PARP inhibitors https://www.abstractsonline.com/pp8/#!/10517/presentation/12967

2659 / 2 - Inhibition of PI3K sensitized cancer cells to Tumor Treating Fields (TTFields) https://www.abstractsonline.com/pp8/#!/10517/presentation/15079

3156 / 7 - Tumor Treating Fields reduce cellular survival of human mesenchymal stromal cells via apoptosis and senescence induction https://www.abstractsonline.com/pp8/#!/10517/presentation/14670

3252 / 21 - Tumor treating fields suppression of ciliogenesis enhances temozolomide toxicity https://www.abstractsonline.com/pp8/#!/10517/presentation/16105

3447 / 5 - Tumor treating fields (TTFields) treatment planning for a patient with astrocytoma in the spinal cord https://www.abstractsonline.com/pp8/#!/10517/presentation/12120

3450 / 8 - Impact of model inaccuracy on dose estimation in TTFields therapy https://www.abstractsonline.com/pp8/#!/10517/presentation/12124

3465 / 23 - Efficacy of concomitant application of Tumor Treating Fields (TTFields), temozolomide and lomustine in glioblastoma cancer cells in vitro https://www.abstractsonline.com/pp8/#!/10517/presentation/18151

CT234 / 5 - PANOVA-3: A phase 3 study of tumor treating fields with gemcitabine and nab-paclitaxel for front-line treatment of locally advanced pancreatic adenocarcinoma https://www.abstractsonline.com/pp8/#!/10517/presentation/20361